During the past decade, Hospital Universitario Virgen macarena conducted 368 clinical trials. In the 10-year time frame, 368 clinical trials started and 111 clinical trials were completed, i.e. on average, 30.2% percent of trials that started reached the finish line to date. In the past 5 years, 209 clinical trials started and 83 clinical trials were completed. i.e. 39.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Virgen macarena" #1 sponsor was "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 36 trials, followed by "Pfizer" with 28 trials sponsored, "Hoffmann-La Roche" with 26 trials sponsored, "Eli Lilly and Company" with 16 trials sponsored and "Janssen Research & Development, LLC" with 16 trials sponsored. Other sponsors include 361 different institutions and companies that sponsored additional 218 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Virgen macarena" #1 collaborator was "AstraZeneca" with 10 trials as a collaborator, "Hospital Universitario Virgen Macarena" with 10 trials as a collaborator, "Merck Sharp & Dohme LLC" with 10 trials as a collaborator, "Bristol-Myers Squibb" with 8 trials as a collaborator and "Eli Lilly and Company" with 8 trials as a collaborator. Other collaborators include 288 different institutions and companies that were collaborators in the rest 216 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Virgen macarena" are "Breast Cancer" (27 trials), "Crohn Disease" (10 trials), "Atrial Fibrillation" (8 trials), "Arthritis, Rheumatoid" (7 trials) and "Breast Neoplasms" (7 trials). Many other conditions were trialed in "Hospital Universitario Virgen macarena" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Virgen macarena" are "Drug" (345 trials), "Other" (47 trials), "Biological" (35 trials), "Device" (26 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (90 trials), "Carboplatin" (11 trials), "Cisplatin" (11 trials), "Pembrolizumab" (11 trials) and "Gemcitabine" (10 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Virgen macarena" are 448 trials for "All" genders, 36 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Virgen macarena". 3 are not yet recruiting, 114 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 227 completed trials in Hospital Universitario Virgen macarena, undefined suspended trials, and 45 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Virgen macarena, 38 "Phase 1" clinical trials were conducted, 133 "Phase 2" clinical trials and 189 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 34 trials, and there were also 24 trials that are defined as “Not Applicable".

Hospital Universitario Virgen macarena has several departments that took part in Clinical trials: "Hospital Universitario Virgen Macarena; Servicio de Oncologia" - 25 trials, "Hospital Universitario Virgen Macarena; Servicio de Neurologia" - 13 trials, "Hospital Universitario Virgen Macarena; Servicio de Hematologia" - 3 trials, "Hosp Univ Virgen Macarena - Dpt Cardiology" - 2 trials, "Hospital Virgen Macarena (policlinico) 2ª planta Servicio de Endocrinologia y Nutricion" - 2 trials